Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY

NCT03350178 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped recruitment shortened

Conditions

Intensive Care Units
Fecal Microbiota Transplantation

Interventions

DRUG: fecal microbiota transfer

Sponsor

MaaT Pharma